Lunit Inc

Lunit Inc has a debt-to-equity ratio of 0.81, indicating a moderate level of leverage, while its current ratio of 0.26 suggests a significant liquidity risk, as current assets are insufficient to cover current liabilities. The company's cash and equivalents amount to 14,110.6 million KRW, but this is far below the long-term debt of 111,583.1 million KRW, resulting in a net cash position that is negative after subtracting total debt. The operating cash flow is negative at -55,175.2 million KRW, and the free cash flow is also negative at -46,715.8 million KRW, indicating that the company is not generating sufficient cash from operations to sustain its activities. In terms of profitability, Lunit Inc reported a net loss of 47,389.7 million KRW and an operating loss of 83,103.9 million KRW, with a return on equity of -34.48% and a return on assets of -12.81%. These figures are significantly below the industry median for profitability metrics, suggesting that the company is underperforming relative to its peers in the Advanced Medical Equipment & Technology industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to market-specific risks, particularly in the South Korean healthcare technology market. Looking ahead, Lunit Inc is expected to face continued financial pressure, as its operating and net losses are likely to persist in the near term. The company's capital expenditure of -9,633.4 million KRW indicates ongoing investment in infrastructure, but without a corresponding increase in revenue, this may further strain its financial position. Analysts have not issued any strong buy or buy recommendations, with a mean recommendation of 4.00, indicating a neutral to slightly negative outlook. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The primary risk factor is the negative net cash position after subtracting total debt, which could limit the company's ability to fund operations or respond to unexpected events. There is no indication of near-term dilution pressure, as the number of shares outstanding has not changed between basic and diluted shares. Recent filings and transcripts have not revealed any material events that would significantly alter the company's financial trajectory. However, the continued operating losses and negative cash flows suggest that the company may need to secure additional financing or implement cost-cutting measures to remain viable.